Globus Medical, Inc. (GMED) Tops Q1 EPS by 2c

Globus Medical, Inc. (NYSE: GMED) reported Q1 EPS of $0.24, $0.02 better than the analyst estimate of $0.22. Revenue for the quarter came in at $114.2 million versus the consensus estimate of $113.59 million.

For earnings history and earnings-related data on Globus Medical, Inc. (GMED) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c